This inventor holds 1 USPTO granted patent. Top assignees: Otsuka Pharmaceutical Company, Limited, Taiho Pharmaceutical Company Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 846 
1 out of 320 
Years Active: 2024
Title: Ryo Kato - Innovator in Heterobicyclic Compounds
Introduction
Ryo Kato is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on heterobicyclic compounds.
Latest Patents
Ryo Kato holds a patent for "Heterobicyclic compounds for inhibiting the activity of SHP2." This invention provides a compound of formula (I), which has potential applications in medical treatments.
Career Highlights
Throughout his career, Ryo Kato has worked with prominent companies in the pharmaceutical industry, including Taiho Pharmaceutical Company Limited and Otsuka Pharmaceutical Company, Limited. His work has been instrumental in advancing drug development and therapeutic solutions.
Collaborations
Ryo Kato has collaborated with talented individuals such as Tadashi Shimamura and Risako Miura. These partnerships have contributed to the success of his projects and innovations.
Conclusion
Ryo Kato's contributions to the field of pharmaceuticals through his patent on heterobicyclic compounds highlight his role as an influential inventor. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile